Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 22, Issue 3, 2007, Pages 819-826

  Toprak, Omer ^a   Cirit, Mustafa ^a   Yesil, Murat ^a   Bayata, Serdar ^a   Tanrisev, Mehmet ^a   Varol, Umut ^a   Ersoy, Rifki ^a   Esi, Ertap ^a  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Contrast induced nephropathy; Coronary angiography; Diabetes mellitus; Pre diabetes; Renal insufficiency

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; IOHEXOL; URIC ACID;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOGENIC SHOCK; CHRONIC KIDNEY DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE CLEARANCE; DEATH; DIABETES MELLITUS; DIET RESTRICTION; DRUG USE; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEART ARREST; HEART REINFARCTION; HEMODIALYSIS; HUMAN; HYPERTENSION; HYPERURICEMIA; IMPAIRED GLUCOSE TOLERANCE; KIDNEY DISEASE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE;

BLOOD GLUCOSE; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CREATININE; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; HYPERGLYCEMIA; INCIDENCE; IOHEXOL; KIDNEY FAILURE, CHRONIC; LENGTH OF STAY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY; RISK FACTORS; TURKEY; URIC ACID;

EID: 33847623598     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl636     Document Type: Article

References (30)

1. Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy: A clinical and evidence-based approach. Circulation 2006; 113: 1799-1806
2. Toprak O, Cirit M. Risk factors for contrast-induced nephropathy. Kidney Blood Press Res 2006; 29: 84-93
3. McCullough P. Outcomes of contrast-induced nephropathy: Experience in patients undergoing cardiovascular intervention. Catheter Cardiovasc Interv 2006; 67: 335-343
4. Solomon R, Barrett B. Follow-up of patients with contrast-induced nephropathy. Kidney Int 2006; 100: S46-S50
5. Rihal CS, Textor SC, Grill DE et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105: 2259-2264
6. The Expert Committee on the Diagnosis1 and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160-3167
7. Babu A, Fogelfeld L. Metabolic syndrome and prediabetes. Dis Mon 2006; 52: 55-144
8. Wiernsperger NF. Oxidative stress as a therapeutic target in diabetes: revisiting the controversy. Diabetes Metab 2003; 29: 579-585
9. Rodriguez CJ, Miyake Y, Grahame-Clarke C et al. Relation of plasma glucose and endothelial function in a population-based multiethnic sample of subjects without diabetes mellitus. Am J Cardiol 2005; 96: 1273-1277
10. Deedwania PC, Fonseca VA. Diabetes, prediabetes, and cardiovascular risk: Shifting the paradigm. Am J Med 2005; 118: 939-947
11. Knudson JD, Rogers PA, Dincer UD et al. Coronary vasomotor reactivity to endothelin-1 in the prediabetic metabolic syndrome. Microcirculation 2006; 13: 209-218
12. Detrenis S, Meschi M, Musini S, Savazzi G. Lights and shadows on the pathogenesis of contrast-induced nephropathy: State of the art. Nephrol Dial Transplant 2005; 20: 1542-1550
13. Pannu N, Wiebe N, Tonelli M. Alberta Kidney Disease Network. Prophylaxis strategies for contrast-induced nephropathy. JAMA 2006; 295: 2765-2779
14. Lautin EM, Freeman NJ, Schoenfeld AH et al. Radiocontrast-associated renal dysfunction: Incidence and risk factors. AJR Am J Roentgenol 1991; 157: 49-58
15. Parfrey PS, Griffiths SM, Barrett BJ et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 1989; 320: 143-149
16. Benjamin SM, Valdez R, Geiss LS, Rolka DB, Narayan KM. Estimated number of adults with prediabetes in the US in 2000: Opportunities for prevention. Diabetes Care 2003; 26: 645-649
17. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003; 52: 1210-1214
18. Fox CS, Larson MG, Leip EP, Meigs JB, Wilson PW, Levy D. Glycemic status and development of kidney disease: The Framingham Heart Study. Diabetes Care 2005; 28: 2436-2440
19. Kramer H, Molitch ME. Screening for kidney disease in adults with diabetes. Diabetes Care 2005; 28: 1813-1816
20. Diamant M, Tushuizen ME. The metabolic syndrome and endothelial dysfunction: Common highway to type 2 diabetes and CVD. Curr Diab Rep 2006; 6: 279-286
21. Festa A, Hanley AJ, Tracy RP, D'Agostino R,Jr, Haffner SM. Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion. Circulation 2003; 108: 1822-1830
22. Kanauchi M, Kawano T, Kanauchi K, Saito Y. New 'prediabetes' category and the metabolic syndrome in Japanese. Horm Metab Res 2005; 37: 622-626
23. Schwarz PE, Bornstein SR. Pre-diabetes and metabolic syndrome in Germans. Horm Metab Res 2006; 38: 359
24. Toprak O, Cirit M, Yesil M et al. Metabolic syndrome as a risk factor for contrast-induced nephropathy in non-diabetic elderly patients with renal impairment. Kidney Blood Press Res 2006; 29: 2-9
25. Cirit M, Toprak O, Yesil M et al. Angiotensin-converting enzyme inhibitors as a risk factor for contrast-induced nephropathy. Nephron Clin Pract 2006; 104: C20-c27
26. Gupta RK, Kapoor A, Tewari S, Sinha N, Sharma RK. Captopril for preventing of contrast-induced nephropathy in diabetic patients: A randomized study. Indian Heart J 1999; 51: 521-526
27. Toprak O, Cirit M, Bayata S, Yeşil M, Aslan LS. The effect of pre-procedural captopril on contrast media Induced nephropathy who underwent coronary angiography. Anadolu Kardiyol Derg 2003; 3: 98-103
28. Toprak O, Cirit M, Esi E, Postaci N, Yesil M, Bayata S. Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with renal dysfunction. Catheter Cardiovasc Interv 2006; 67: 227-235
29. Parfrey P. The clinical epidemiology of contrast-induced nephropathy. Cardiovasc Intervent Radiol 2005; 28: S3-S11
30. Hojs R, Bevc S, Ekart R, Gorenjak M, Puklavec L. Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function. Nephrol Dial Transplant 2006; 21: 1855-1862